The Use of Maggot Therapy and Tissue Engineering for Wound Chronic Treatment

Maggot therapy is mentioned in holy books. After the introduction of antibiotics to the market, a long period of delay occurred in using maggot therapy method. In recent years, due to resistance of infectious agents against antibiotics, there has been a good return to this method. In 1999, WHO confirmed this science and included it in its remedial policies. Maggot therapy was approved by FDA in 2004. Tissue engineering means development and change in experimental growth of cells in tissues or limbs, in order to substitute or heal the damaged part of the body. The main problem of serious wounds is the risk of infection, their depths and loss of tissue. Integrated use of maggot therapy and tissues engineering is a bridge between two ancient and modern methods which is very effective for curing diabetic wounds and bedsore. Due to high probability of success in this method, development and use of the above-mentioned method is highly recommended and it is necessary to use this method in our country widely.